Bio-Rad Laboratories, Inc. logo
Bio-Rad Laboratories, Inc. (BIO)
Compare

Bio-Rad Laboratories, Inc. (BIO) Research & Development Expenses

The r&d expense for Bio-Rad Laboratories, Inc. (BIO) is $256.90 Million with a year-over-year change of -13.18%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.

BIO R&D Expense Chart

BIO R&D Expense
$256.90M+123.19% 20Y
Zoom

Current R&D Expense

$256.90M

$256.90 Million

Year-over-Year Change

-13.18%

vs. $295.90M prior year

Historical Data

30

Years of data available

Annual R&D Expense History

YearR&D ExpenseYoY Change% Change
2025$256.90M$-39.00M-13.18%
2024$295.90M+$48.47M+19.59%
2023$247.43M$-9.46M-3.68%
2022$256.89M$-3.75M-1.44%
2021$260.64M+$42.88M+19.69%
2020$217.76M+$15.05M+7.43%
2019$202.71M+$3.51M+1.76%
2018$199.20M$-51.10M-20.42%
2017$250.30M+$44.44M+21.59%
2016$205.86M+$12.89M+6.68%
2015$192.97M$-27.36M-12.42%
2014$220.33M+$9.38M+4.45%
2013$210.95M$-3.09M-1.44%
2012$214.04M+$27.60M+14.80%
2011$186.44M+$14.17M+8.23%
2010$172.27M+$8.68M+5.31%
2009$163.59M+$4.07M+2.55%
2008$159.52M+$18.98M+13.51%
2007$140.53M+$17.16M+13.91%
2006$123.38M+$8.27M+7.19%
2005$115.10M+$6.76M+6.24%
2004$108.34M+$14.07M+14.93%
2003$94.27M+$11.34M+13.67%
2002$82.94M+$6.39M+8.35%
2001$76.54M+$8.40M+12.33%
2000$68.14M+$16.94M+33.09%
1999$51.20M+$9.80M+23.67%
1998$41.40M$-4.70M-10.20%
1997$46.10M+$6.50M+16.41%
1996$39.60M
Data as of Wednesday, June 10, 2026

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA
7,700 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz